FeverText: Assessing Fever Rates After Influenza and Pneumococcal Vaccination During the 2011-12 Influenza Season Using Text Messaging
Phase of Trial: Phase IV
Latest Information Update: 31 Jul 2012
At a glance
- Drugs Influenza virus vaccine (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Influenza virus infections; Pneumococcal infections
- Focus Adverse reactions
- 31 Jul 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 31 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Nov 2011 Actual initiation date (November 2011) added as reported by ClinicalTrials.gov.